We are live on !
Find out more
nVerses Capital Portfolio holdings
AUM
$65M
Turnover
88.28%
This Fund
S&P 500
This Quarter Est. Return
+23.86%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65M
AUM Growth
-$45M
(-41%)
Cap. Flow
-$50M
Cap. Flow % of AUM
Cap. Flow %
-76.84%
Top 10 Holdings %
Top 10 Hldgs %
9.2%
Holding
563
New
215
Increased
19
Reduced
47
Closed
282
Avg Time Held
0.1
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$635K |
| 2 |
Knight Transportation
KNX
|
+$625K |
| 3 |
AbbVie
ABBV
|
+$624K |
| 4 |
SM Energy
SM
|
+$576K |
| 5 |
Target
TGT
|
+$556K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seagate
STX
|
+$807K |
| 2 |
Lam Research
LRCX
|
+$789K |
| 3 |
Comfort Systems
FIX
|
+$779K |
| 4 |
Intuitive Surgical
ISRG
|
+$778K |
| 5 |
Blue Owl Capital
OBDC
|
+$766K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.8% |
| 2 | Technology | 16.28% |
| 3 | Industrials | 14.57% |
| 4 | Financials | 14.31% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Neurocrine Biosciences
NBIX
$17.1B
| $212K | 0.33% |
+1,259
| New | +$187K |
2026 Q2
0 quarters
|
|
177
Raymond James Financial
RJF
$32.2B
| $212K | 0.33% |
+1,394
| New | +$212K |
2026 Q2
0 quarters
|
|
178
Rhythm Pharmaceuticals
RYTM
$7.62B
| $212K | 0.33% |
+1,908
| New | +$173K |
2026 Q2
0 quarters
|
|
179
Alaska Air
ALK
$4.4B
| $211K | 0.32% |
+4,039
| New | +$173K |
2026 Q2
0 quarters
|
|
180
Riot Platforms
RIOT
$6.69B
| $211K | 0.32% |
+7,699
| New | +$174K |
2026 Q2
0 quarters
|
|
181
Colony Bankcorp
CBAN
$554M
| $208K | 0.32% |
10,360
-2,551
| -20% | -$51.6K |
2026 Q1
1 quarter
|
|
182
3M
MMM
$96B
| $208K | 0.32% |
+1,283
| New | +$194K |
2026 Q2
0 quarters
|
|
183
United States Lime & Minerals
USLM
$3.28B
| $207K | 0.32% |
+1,982
| New | +$230K |
2026 Q2
0 quarters
|
|
184
Graphic Packaging
GPK
$3.19B
| $207K | 0.32% |
+19,560
| New | +$200K |
2026 Q2
0 quarters
|
|
185
FormFactor
FORM
$7.22B
| $206K | 0.32% |
+1,288
| New | +$171K |
2026 Q2
0 quarters
|
|
186
BridgeBio Pharma
BBIO
$15.2B
| $205K | 0.32% |
+2,753
| New | +$193K |
2026 Q2
0 quarters
|
|
187
Travel + Leisure Co
TNL
$4.71B
| $205K | 0.31% |
+2,678
| New | +$188K |
2026 Q2
0 quarters
|
|
188
Cars.com
CARS
$669M
| $204K | 0.31% |
+18,667
| New | +$190K |
2026 Q2
0 quarters
|
|
189
Xcel Energy
XEL
$52.3B
| $204K | 0.31% |
2,538
-1,581
| -38% | -$126K |
2024 Q1
9 quarters
|
|
190
Griffon
GFF
$4.75B
| $204K | 0.31% |
+2,088
| New | +$182K |
2026 Q2
0 quarters
|
|
191
PENN Entertainment
PENN
$2.35B
| $202K | 0.31% |
+9,449
| New | +$169K |
2026 Q2
0 quarters
|
|
192
A10 Networks
ATEN
$2.11B
| $202K | 0.31% |
5,401
-23,718
| -81% | -$689K |
2026 Q1
1 quarter
|
|
193
Collegium Pharmaceutical
COLL
$775M
| $202K | 0.31% |
+5,574
| New | +$190K |
2026 Q2
0 quarters
|
|
194
Atlas Energy Solutions
AESI
$689M
| $201K | 0.31% |
+12,097
| New | +$198K |
2026 Q2
0 quarters
|
|
195
Exelixis
EXEL
$17B
| $200K | 0.31% |
+3,682
| New | +$179K |
2026 Q2
0 quarters
|
|
196
Priority Technology Holdings
PRTH
$653M
| $197K | 0.3% |
29,515
+15,570
| +112% | +$90.1K |
2026 Q1
1 quarter
|
|
197
Via Transportation Inc
VIA
$3.47B
| $196K | 0.3% |
+10,787
| New | +$169K |
2026 Q2
0 quarters
|
|
198
Peloton Interactive
PTON
$2.47B
| $196K | 0.3% |
+33,096
| New | +$179K |
2026 Q2
0 quarters
|
|
199
MeiraGTx Holdings
MGTX
$844M
| $190K | 0.29% |
+14,062
| New | +$140K |
2026 Q2
0 quarters
|
|
200
Figma
FIG
$10.1B
| $187K | 0.29% |
+10,356
| New | +$208K |
2026 Q2
0 quarters
|
|
Similar funds
OC
KL
nVerses Capital's Q2 2026 Portfolio in Review
As of Q2 2026, nVerses Capital held 563 positions worth $65M, down 41% from $110M the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
nVerses Capital withdrew a net $50M in Q2 2026, closing 282 positions and reducing 47 holdings. Its most notable exit was Lam Research, an estimated $789K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
Against the trend, nVerses Capital opened a new position in Walmart Inc worth $579K.
- nVerses Capital's largest Q2 2026 buy was Walmart Inc: 5,116 shares worth $579K.
- nVerses Capital added most to CenterPoint Energy in Q2 2026, an estimated $263K increase.
- nVerses Capital's biggest Q2 2026 reduction was Seagate, cutting an estimated $807K.
- nVerses Capital fully exited Lam Research in Q2 2026, selling an estimated $789K.
- nVerses Capital's ten largest holdings make up 9.2% of its $65M portfolio in Q2 2026.
- nVerses Capital opened 215 new positions and closed 282 in Q2 2026.
- nVerses Capital's portfolio value fell 41% quarter-over-quarter to $65M.
Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.